- Revenue 2024
- $2,012,099
- Expenses 2024
- $1,794,414
Program services were 70.1% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
As filed
- Subsection
- 03
- NTEE code
- P82Z
- Classification
- 1000
- Street
- 6950 COLUMBIA GATEWAY DR STE 370
These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).
Mission and programs · 2024
Mission
The mission of The Myositis Association, or TMA, is: to improve the lives of persons affected by myositis, fund innovative research, and increase myositis awareness and advocacy. TMA is the premier international organization providing important resources, education and support to those in the myositis community. This community consists of children, adults, and their families who live with the daunting and life-changing physical, psychological and emotional effects of myositis. Nationwide, an estimated 75,000 Americans are affected by this collection of rare diseases. Symptoms of myositis include, but are not limited to: muscle weakness pain fatigue tripping or falling trouble swallowing difficulty breathing and irritations of the skin, joints, and eyes. Myositis is often difficult to diagnose, because many physicians are unfamiliar with the disease and its symptoms. Also, as a rare disease, it can be difficult to enroll enough patients to conduct adequate research of new treatments, an
-
Global Myositis Patient Conference: TMA has convened myositis patients, care partners, and clinicians for a multi-day conference focused on learning and community-building since 1995. TMA's International Annual Patient Conference (IAPC) is now an annual event with panels of medical experts, peer counseling, sessions on coping skills, exercise workshops, and time to meet other patients and their families. The 2024 IAPC took place in Baltimore, Maryland, US, from Sept. 4-7. The conference included our first off-site medical and sightseeing excursions; TMA's Heroes in the Fight Awards; and a virtual recordings package to extend the reach of our conference breakout sessions. Many of TMA's members cannot travel, due to the progressively debilitating nature of their form of myositis. TMA offers the conference recordings at a discounted price to share the learnings from TMA's IAPC as widely and inclusively as possible.
Expenses $527,150 · Grants $15,084 · Revenue $433,403
-
Research Grants: TMA aims to identify the underlying causes and natural progression of myositis, develop better treatments and more effective therapies, and ultimately to arrive at cures for this collection of disabling diseases. Through our research program, we progress toward a world without myositis. Twelve TMA grants were active in 2024. We continued our research fellowship program to attract and encourage post-doctoral trainees (PhD and MD) and early-career physicians to pursue careers in the field of myositis research, and funded innovative pilot projects. From 2002 to 2024, TMA has awarded 68 research grants totaling nearly $8 million. Two new projects were approved in 2024: "Senolytic therapies in a novel patient-derived myoblast model of inclusion body myositis and Mitochondrial contribution to juvenile dermatomyositis." The grants portfolio is designed to advance our collective understanding of inclusion body myositis, dermatomyositis, necrotizing myopathy, polymyositis, and all forms of myositis. Scientists, practicing physicians, and other medical professionals have supported TMA through our active Medical Advisory Board. This group provides medical information to staff and patients, and guides the TMA research program.
Expenses $407,313 · Grants $316,132
-
Other Program Services: TMA's other initiatives are focused on awareness, advocacy, and clinician outreach. We are continually updating approximately 13,000 members through monthly e-newsletters, quarterly magazines, videos on YouTube, social media channels, and the highly trafficked website myositis.org. Our efforts to elevate the understanding of myositis among the general public are very important. Because these diseases are very rare, advocacy on behalf of the families affected by myositis is a core component of our mission. In 2024, we organized Myositis Awareness Month from May 1-31, 2024 and we participated in World Myositis Day on September 21, 2024. TMA also provides resources for healthcare professionals, to ensure that they receive the latest information on treating myositis and communicating effectively with their patients. We publish various resources, including our "Myositis 101" physician booklets, disease overview brochures, and infographics. In 2024, we hosted a myositis research symposium for physicians and experts during our Global Myositis Patient Conference; we co-hosted an Externally-Led Patient-Focused Drug Development meeting with regulatory decision-makers and MSU; and we co-hosted a summit featuring "Recent Advances in Myositis Research and Treatment" with the Cure Juvenile Myositis (JM) Foundation.
Expenses $186,301
-
Patient Support and Education: TMA's Support Groups offer members the chance to share their feelings and discuss their concerns with people in similar situations. These groups, which are offered in-person and virtually, encourage an atmosphere of communication and compassion. TMA also administers Affinity Groups with outreach targeted toward supporting and extending our organization's reach into new communities. Through Affinity Groups, TMA brings together of people who have commonality such as Military Veterans, Women with IBM, Women of Color, Care Partners, and more. TMA's 36 regional Support Groups and 8 virtual Affinity Groups welcomed nearly 4,000 patients and care partners to group meetings in 2024. TMA's educational efforts, especially those organized during Myositis Awareness Month and World Myositis Day, create broader community awareness, direct our members to TMA offerings and resources, educate around patient and disease advocacy, share clinical insights, and build a stronger and more connected myositis community. TMA resources share information on diagnosis, treatments, research news, and other relevant topics that help patients and care partners learn what they need to address their individual health care concerns. TMA additionally hosts webinars year-round, including our monthly Ask the Expert series as well as Research Insights, Empowerment Clinic, and Awareness Clinic offerings. 1,399 registrants participated in TMA's virtual programs in 2024.
Expenses $137,790
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Officers and directors · 2024
As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.
-
Paula Eichenbrenner
Executive Dir.
- Total calculated
- $180,562
- From this org
- $180,562
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $180,562
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- not reported
- Filer's total
- $180,562
-
Laurie Boyer Chair
Director
- Total calculated
- $0
- Hours/week
- 3
-
Rich DeAugustinis Vice Chair
Director
- Total calculated
- $0
- Hours/week
- 1.5
-
Martha Arnold Secretary
Director
- Total calculated
- $0
- Hours/week
- 1.5
-
Howard Gerrin Treasurer
Director
- Total calculated
- $0
- Hours/week
- 1.5
-
Jeff Autrey
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Iazsmin Bauer Ventura
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Richard Chip Galloway
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Holly Jones
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Frank Lipiecki
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Ricky Marks
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
David Mochel
Director
- Total calculated
- $0
- Hours/week
- 1.5
-
Tahseen Mozaffar
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Jane Myles
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Rodger Oren
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Meriel Parker
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Mustafa Shameem
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Nita Sharma
Director
- Total calculated
- $0
- Hours/week
- 0.5
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.
Filings
-
2024
- Revenue
- $2,012,099
- Expenses
- $1,794,414
- Contributions
- $1,576,936
- Grants paid
- $331,216
-
2023
- Revenue
- $1,249,899
- Expenses
- $1,888,477
- Contributions
- $1,189,812
- Grants paid
- $228,536
-
2022
- Revenue
- $1,317,262
- Expenses
- $1,654,469
- Contributions
- $1,435,059
- Grants paid
- $332,573
The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.
Other returns filed
-
2024 · 990-T
- Revenue
- not reported
- Expenses
- not reported
- Assets (EOY)
- not reported
-
2023 · 990-T
- Revenue
- not reported
- Expenses
- not reported
- Assets (EOY)
- not reported
-
2021 · 990
- Revenue
- $1,770,917
- Expenses
- $1,269,788
- Assets (EOY)
- $2,957,547
-
2020 · 990
- Revenue
- $1,179,750
- Expenses
- $1,183,055
- Assets (EOY)
- $2,242,240
-
2019 · 990
- Revenue
- $1,016,099
- Expenses
- $1,622,977
- Assets (EOY)
- $2,226,058
-
2018 · 990
- Revenue
- $1,762,199
- Expenses
- $1,584,809
- Assets (EOY)
- $2,838,260
-
2017 · 990
- Revenue
- $1,757,990
- Expenses
- $1,753,124
- Assets (EOY)
- $2,707,789
-
2016 · 990
- Revenue
- $1,399,213
- Expenses
- $1,544,574
- Assets (EOY)
- $2,607,075
-
2015 · 990
- Revenue
- $1,530,309
- Expenses
- $1,378,390
- Assets (EOY)
- $2,693,796
-
2014 · 990
- Revenue
- $2,704,998
- Expenses
- $1,337,435
- Assets (EOY)
- $2,600,936
Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.
Grants made
-
$100,000
2022 Research Grant
-
$80,000
2022 Research Grant
-
$75,000
2022 Research Grant
-
$50,000
2023 Research Grant
-
$50,000
2024 Research Grant
-
$50,000
2023 Research Grant
-
$50,000
2023 Research Grant
-
$25,000
2022 Research Grant
-
$25,000
2024 Research Grant
-
$12,363
2022 Patient Advocacy
The 10 largest by cash amount. The API serves every itemized grant.
Grants received
-
DONOR ADVISED CHARITABLE GIVING
$89,214
2024 HUMAN SERVICES
-
2024 For grant recipient's exempt purposes
-
$32,883
2022 UNRESTRICTED
-
2023 For grant recipient's exempt purposes
-
2023 GENERAL SUPPORT
-
2023 GENERAL SUPPORT
-
2024 GENERAL SUPPORT
-
2022 HEALTH
-
$14,000
2023 HUMAN SERVICE
-
$13,000
2024 HUMAN SERVICE
The 10 largest by cash amount. The API serves every itemized grant.
Other IRS files
Auto-Revocation List
Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.
Publication 78
Listed as of 13 October 2026, under deductibility PC.
These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.
What this page reflects
The registration facts above come from the IRS Business Master File published 13 October 2026 and read 26 October 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.